COX Inhibitors

COX

COX-1

COX-2

COX-3

COX Inhibitors, Activators & Modulators

Product Name	COX	COX-1	COX-2	COX-3	Purity
Acetaminophen		COX-1, IC₅₀: 113.7 μM	COX-2, IC₅₀: 25.8 μM		99.98%
Indomethacin		Human COX-1, IC₅₀: 18 nM (in CHO cells)	Human COX-2, IC₅₀: 26 nM (in CHO cells)		99.91%
EIPA			COX-2		99.73%
Celecoxib		COX-1, IC₅₀: 15 μM	COX-2, IC₅₀: 40 nM		99.09%
Aspirin		COX-1, IC₅₀: 27.75 μM	COX-2, IC₅₀: 1.17 mM		99.82%
Oxidopamine hydrobromide			COX-2		99.95%
Oxidopamine hydrochloride			COX-2		99.91%
Gallic acid			COX-2		99.98%
Diclofenac		Human COX-1, IC₅₀: 4 nM (in CHO cells) Ovine COX-1, IC₅₀: 5.1 μM	Human COX-2, IC₅₀: 1.3 nM (in CHO cells) Ovine COX-2, IC₅₀: 0.84 μM		99.92%
Ibuprofen		COX-1, IC₅₀: 13 μM	COX-2, IC₅₀: 370 μM		99.97%
Catechin		COX-1, IC₅₀: 1.4 μM			99.57%
20(S)-Ginsenoside Rg3			COX-2		99.94%
(-)-Epicatechin		COX-1, IC₅₀: 3.2 μM			99.00%
Meloxicam		COX-1, IC₅₀: 36.6 μM	COX-2, IC₅₀: 0.49 μM		99.70%
Naproxen		COX-1, IC₅₀: 9.55 μM	COX-2, IC₅₀: 5.65 μM		99.98%
Diclofenac Sodium		Human COX-1, IC₅₀: 4 nM (in CHO cells) Ovine COX-1, IC₅₀: 5.1 μM	Human COX-2, IC₅₀: 1.3 nM (in CHO cells) Ovine COX-2, IC₅₀: 0.84 μM		99.94%
NS-398			COX-2, IC₅₀: 3.8 μM		99.72%
Carprofen		COX-1, IC₅₀: 22.3 μM	COX-2, IC₅₀: 3.9 μM		99.76%
Xanthohumol		COX-1	COX-2		99.97%
Salicylic acid			COX-2		98.42%
Rebamipide			COX-2		99.94%
(-)-Epicatechin gallate		COX-1, IC₅₀: 7.5 μM			98.57%
Phenacetin				COX-3, IC₅₀: 102 μM	99.94%
EIPA hydrochloride			COX-2		98.31%
(S)-(+)-Ibuprofen		COX-1, IC₅₀: 2.1 μM	COX-2, IC₅₀: 1.6 μM		99.98%
Ketoprofen		COX-1, IC₅₀: 2 nM (in human blood monocytes)	COX-2, IC₅₀: 26 nM (in human blood monocytes)		99.95%
Iguratimod			COX-2, IC₅₀: 20 μM		99.93%
Piroxicam		COX-1, IC₅₀: 47 μM (in human monocytes)	COX-2, IC₅₀: 25 μM (in human monocytes)		99.71%
SC-560		COX-1, IC₅₀: 9 nM	COX-2, IC₅₀: 6.3 μM		99.79%
Psoralidin			COX-2		99.90%
Parecoxib			COX-2		99.29%
Ginsenoside Rd			COX-2		99.88%
Isoorientin			COX-2, IC₅₀: 39 μM		99.26%
Ginsenoside C-K			COX-2		99.92%
Aspirin (Standard)		COX-1	COX-2		99.85%
Sodium Salicylate			COX-2		99.93%
Neochlorogenic acid			COX-2		99.77%
Prim-O-glucosylcimifugin			COX-2		99.94%
Mefenamic acid		hCOX-1, IC₅₀: 40 nM	hCOX-2, IC₅₀: 3 μM		99.95%
Rutaecarpine		COX-1, IC₅₀: 8.7 μM (in BMMC)	COX-2, IC₅₀: 0.28 μM (in BMMC)		99.00%
Niflumic acid			COX-2, IC₅₀: 100 nM		99.88%
Diflunisal	COX				99.93%
Ginsenoside Rg5			COX-2		99.87%
Guaiacol			COX-2		99.41%
Gamma-Mangostin			COX-2		99.91%
Salicin	COX				99.77%
Nimesulide			COX-2, IC₅₀: 0.07-70 μM		99.90%
Flurbiprofen	COX	COX-1	COX-2		99.98%
Paradol			COX-2		99.42%
Harpagoside		COX-1	COX-2		99.41%
Fenofibric acid			COX-2, IC₅₀: 48 μM		99.94%
Rofecoxib			Human COX-2, IC₅₀: 18 nM (in Chinese hamster ovary cells) Human COX-2, IC₅₀: 26 nM (in human osteosarcoma cells)		99.84%
Etoricoxib		COX-1, IC₅₀: 116 μM (in human whole blood)	COX-2, IC₅₀: 1.1 μM (in human whole blood)		99.90%
Isofraxidin			COX-2		99.00%
Broussonin E			COX-2		98.18%
Valdecoxib		COX-1, IC₅₀: 140 μM	COX-2, IC₅₀: 5 nM		99.90%
Avicularin			COX-2		99.80%
Indobufen	COX				99.98%
Cafestol			COX-2		99.91%
Madecassic acid			COX-2		99.23%
Roburic acid		COX-1, IC₅₀: 5 μM	COX-2, IC₅₀: 9 μM		≥98.0%
Ibuprofen sodium		COX-1, IC₅₀: 13 μM	COX-2, IC₅₀: 370 μM		99.98%
[10]-Shogaol			COX-2, IC₅₀: 7.5 μM		99.88%
Lumiracoxib		COX-1, Ki: 3 μM	COX-2, Ki: 0.06 μM		99.65%
Tolfenamic Acid			COX-2, IC₅₀: 13.49 μM (in cell)		99.94%
cis-5-Dodecenoic acid		COX-1	COX-2		99.76%
Licofelone	COX, IC₅₀: 0.21 μM				≥99.0%
γ-Tocopherol	Cyclooxygenase				99.63%
Bromfenac sodium		COX-1, IC₅₀: 5.56 nM	COX-2, IC₅₀: 7.45 nM		98.52%
Ethyl Caffeate			COX-2		98.89%
Pectolinarigenin			COX-2		99.59%
SC-236		COX-1, IC₅₀: 17.8 μM	COX-2, IC₅₀: 10 nM		99.56%
Imrecoxib		Human COX-1, IC₅₀: 115 nM	Human COX-2, IC₅₀: 18 nM		99.48%
(S)-Flurbiprofen		COX-1, IC₅₀: 0.48 μM	COX-2, IC₅₀: 0.47 μM		99.89%
Lornoxicam		COX-1, IC₅₀: 5 nM (in cells)	COX-2, IC₅₀: 45 nM (in cells)		99.36%
[8]-Shogaol			COX-2, IC₅₀: 17.5 μM		99.93%
Ketorolac		COX-1, IC₅₀: 20 nM	COX-2, IC₅₀: 120 nM		99.93%
Naproxen sodium		COX-1, IC₅₀: 9.55 μM (in intact cells )	COX-2, IC₅₀: 5.65 μM (in intact cells )		99.87%
Ampiroxicam	COX				98.43%
Jaceosidin			COX-2		99.51%
S-(+)-Ketoprofen		COX-1, IC₅₀: 13 μM	COX-2, IC₅₀: 370 μM		99.88%
α-Humulene			COX-2		98.53%
Nabumetone			COX-2		99.90%
NF-κB/MAPK-IN-1			COX-2		98.42%
Etodolac		COX-1, IC₅₀: ∼50000 nM (in CHO cells)	COX-2, IC₅₀: 41 nM (in CHO cells)		99.77%
Syringaldehyde			COX-2, IC₅₀: 19.2 μM		99.96%
Ginsenoside Rb3			COX-2		99.12%
Inulicin			COX-2		99.91%
FK 3311			COX-2		98.04%
Fenoprofen Calcium hydrate	COX				99.69%
Ufenamate			COX-2		99.89%
3,3'-Diiodo-L-thyronine	COX
α-Spinasterol		COX-1, IC₅₀: 16.17 μM	COX-2, IC₅₀: 7.76 μM		99.15%
Oxaprozin		COX-1, IC₅₀: 2.2 μM	COX-2, IC₅₀: 36 μM		99.95%
Parecoxib Sodium			COX-2		99.94%
Ketorolac tromethamine salt		COX-1, IC₅₀: 20 nM	COX-2, IC₅₀: 120 nM		99.91%
Deracoxib			COX-2		99.65%
Gnetol		COX-1, IC₅₀: 0.78 μM			99.86%
Hexahydrocurcumin			COX-2		99.88%
Pranoprofen		COX-1	COX-2		98.65%
Loxoprofen sodium		COX-1, IC₅₀: 6.5 μM	COX-2, IC₅₀: 13.5 μM		99.98%
N-tert-Butyl-α-phenylnitrone			COX-2		99.94%
(-)-Catechin gallate		COX-1	COX-2		99.98%
S-(+)-Marmesin			COX-2		99.04%
(E)-Ethyl p-methoxycinnamate		COX-1, IC₅₀: 1.12 μM	COX-2, IC₅₀: 0.83 μM		99.53%
AG-024322		COX-1, Ki: 2.3 nM	COX-2, Ki: 3 nM		98.53%
Nepafenac		COX-1, IC₅₀: 64.3 μM			99.51%
Zaltoprofen		COX-1, IC₅₀: 1.3 μM	COX-2, IC₅₀: 0.34 μM		99.28%
Tenidap		COX-1, IC₅₀: 0.03 μM	COX-2, IC₅₀: 1.2 μM		99.32%
Salicylic acid-d₆			COX-2		99.83%
Fenbufen		COX-1, IC₅₀: 3.9 μM	COX-2, IC₅₀: 8.1 μM		99.33%
Felbinac		COX-1, IC₅₀: 865.68 nM	COX-2, IC₅₀: 976 nM		99.74%
Eicosatetraynoic acid	COX, ID₅₀: 8 μM				≥99.0%
Tolmetin		Human COX-1, IC₅₀: 0.35 μM	Human COX-2, IC₅₀: 0.82 μM		99.82%
Macelignan			COX-2		99.95%
Aceclofenac		COX-1, IC₅₀: 7.3 μM	COX-2, IC₅₀: 3 μM		99.91%
PTUPB		COX-1, IC₅₀: 100 μM	COX-2, IC₅₀: 1.26 μM		98.69%
Loxoprofen		COX-1, IC₅₀: 6.5 μM (in human whole blood)	COX-2, IC₅₀: 13.5 μM (in human whole blood)		99.80%
Humulone			COX-2		99.46%
Gallic acid hydrate			COX-2		99.81%
Byakangelicol			COX-2		99.87%
Moracin C			COX-2		99.54%
Asaraldehyde			COX-2		99.83%
Acemetacin		COX-1, IC₅₀: 85 μM (in human intact cell)			99.97%
Tenoxicam		COX-1	COX-2		99.93%
Flunixin meglumine		COX-1, IC₅₀: 0.55 μM	COX-2, IC₅₀: 3.24 μM		99.71%
Adelmidrol			COX-2		≥98.0%
CAY10404		COX-1, IC₅₀: >500 μM	COX-2, IC₅₀: 1 nM		99.69%
7,3',4'-Tri-O-methylluteolin			COX-2		99.28%
β-Elemonic acid			COX-2		99.90%
DuP-697		hCOX-1, IC₅₀: 800 nM	hCOX-2, IC₅₀: 10 nM		99.67%
(+)-Catechin hydrate		COX-1, IC₅₀: 1.4 μM			99.59%
TFAP		COX-1, IC₅₀: 0.8 μM			99.98%
Ampyrone	COX				99.72%
Firocoxib		COX-1, IC₅₀: 7.5 μM	COX-2, IC₅₀: 0.13 μM		99.92%
Diclofenac potassium		Human COX-1, IC₅₀: 4 nM (in CHO cells) Ovine COX-1, IC₅₀: 5.1 nM	Human COX-2, IC₅₀: 1.3 nM (in CHO cells) Ovine COX-2, IC₅₀: 0.84 nM		99.99%
Flurbiprofen axetil	COX				99.85%
FR122047		COX-1, IC₅₀: 28 nM			99.55%
Ketorolac-d₅		COX-1, IC₅₀: 20 nM	COX-2, IC₅₀: 120 nM		98.31%
Bromfenac sodium hydrate		COX-1, IC₅₀: 5.56 nM	COX-2, IC₅₀: 7.45 nM		99.94%
Alminoprofen			COX-2		99.91%
SC-58125		hCOX-1, IC₅₀: >100 μM	hCOX-2, IC₅₀: 0.04 μM		99.92%
Sphondin			COX-2		99.70%
2,5-Di-tert-butylhydroquinone			COX-2, IC₅₀: 14.1 μM		99.90%
Phenidone	COX				99.00%
α-Chaconine			COX-2		99.04%
Valeryl salicylate		COX-1			≥99.0%
Phenyl β-D-glucopyranoside			COX-2		99.85%
Diclofenac diethylamine		Human COX-1, IC₅₀: 4 nM (in CHO cells) Ovine COX-1, IC₅₀: 5.1 μM	Human COX-2, IC₅₀: 1.3 nM (in CHO cells) Ovine COX-2, IC₅₀: 0.84 μM		99.96%
Polmacoxib			COX-2, IC₅₀: 0.1 μg/mL		99.70%
β-Amyrone			COX-2		99.87%
BW 755C		COX-1, IC₅₀: 0.65 μg/mL	COX-2, IC₅₀: 1.2 μg/mL
Teriflunomide impurity 3		COX-1, IC₅₀: 30 μM			99.75%
Enflicoxib			COX-2		99.90%
Columbin		COX-1, EC₅₀: 327 μM	COX-2, EC₅₀: 53.1 μM		99.86%
Phenacetin (Standard)				COX-3	99.97%
Fenofibric acid (Standard)			COX-2		99.16%
Isoxicam		COX-1	COX-2		99.83%
Propyphenazone	COX				99.85%
Tolmetin sodium dihydrate		Human COX-1, IC₅₀: 0.35 μM	Human COX-2, IC₅₀: 0.82 μM		99.94%
Nitroflurbiprofen	COX				99.64%
RWJ 63556			COX-2		99.35%
Vedaprofen		COX-1			99.81%
Tebufelone			COX-2		99.52%
Madecassic acid (Standard)			COX-2
Plantanone B		Ovine COX-1, IC₅₀: 21.78±0.2 μM	Ovine COX-2, IC₅₀: 44.01±0.42 μM		99.16%
Otenaproxesul		COX-1	COX-2		98.03%
Nitroaspirin		COX-1
Pamicogrel	Cyclooxygenase				99.44%
Hamaudol		COX-1, IC₅₀: 0.3 mM	COX-2, IC₅₀: 0.57 mM		99.59%
Anemarsaponin B			COX-2
Mofezolac		COX-1, IC₅₀: 1.44 nM	COX-2, IC₅₀: 447 nM		99.34%
Peonidin chloride			COX-2		98.70%
Pelubiprofen			COX-2		99.27%
GW-406381			COX-2		99.69%
Phenethyl ferulate	COX, IC₅₀: 4.35 μM				99.88%
Mavacoxib			COX-2		99.04%
Cimicoxib			COX-2		98.02%
3,9-Dihydroeucomin			COX-2
Indomethacin-d₄		Human COX-1, IC₅₀: 18 nM (in CHO cells)	Human COX-2, IC₅₀: 26 nM (in CHO cells)		99.78%
Acetaminophen (Standard)		COX-1	COX-2		99.94%
Hydrangenol			COX-2		99.33%
SC57666			COX-2, IC₅₀: 26 nM		98.94%
Ketoprofen (lysinate)		COX-1, IC₅₀: 2 nM	COX-2, IC₅₀: 26 nM
COX-2-IN-6			COX-2		98.80%
Aspirin lithium		COX-1	COX-2
Indomethacin sodium		COX-1, IC₅₀: 18 nM	COX-2, IC₅₀: 26 nM
COX-2/5-LOX-IN-3		COX-1, IC₅₀: 45.73 μM	COX-2, IC₅₀: 5.45 μM
(±)-Aiphanol		COX-1, IC₅₀: 1.9 μM	COX-2, IC₅₀: 9.9 μM
COX-2-IN-30		COX-1, IC₅₀: 10.4 μM	COX-2, IC₅₀: 49 nM
PYZ18			COX-2, IC₅₀: 7.07 μM
MCI			COX-2, IC₅₀: 1.23 μM
Akt/NF-κB/MAPK-IN-1			COX-2
Anti-inflammatory agent 20			COX-2
VI-60			COX-2
L 748780		COX-1, IC₅₀: > 100 μM	COX-2, IC₅₀: 0.5 μM
COX-2-IN-27		COX-1, IC₅₀: 13.22 μM	COX-2, IC₅₀: 0.045 μM
iNOS/COX-2-IN-1			COX-2
COX-2-IN-26		COX-1, IC₅₀: 10.61 μM	COX-2, IC₅₀: 0.067 μM
Eltenac		COX-1, IC₅₀: 0.03 μM	COX-2, IC₅₀: 0.03 μM
Cudraflavone B		COX-1	COX-2
COX-1-IN-2		COX-1, IC₅₀: 38.76 nM
Heterophdoid A			COX-2
COX-2-IN-21		COX-1, IC₅₀: 12.4 μM	COX-2, IC₅₀: 0.039 μM
COX-2-IN-19		COX-1, IC₅₀: 117.8 μM	COX-2, IC₅₀: 1.76 μM
(-)-Epicatechin (Standard)		COX-1
Antitumor agent-77			COX-2
Avicularin (Standard)			COX-2
Oxaprozin potassium		COX-1, IC₅₀: 2.2 μM	COX-2, IC₅₀: 36 μM
Mefenamic acid-d₄		hCOX-1, IC₅₀: 40 nM	hCOX-2, IC₅₀: 3 nM		≥98.0%
COX-1/2-IN-3		COX-1	COX-2
Antitumor agent-78			COX-2
COX-2-IN-17		COX-1, IC₅₀: >10 μM	COX-2, IC₅₀: 0.02 μM
(-)-Epicatechin gallate (Standard)		COX-1
LM-4108		Ovine COX-1, IC₅₀: >66 μM	Human COX-2, IC₅₀: 60 nM
COX-2-IN-44		COX-1, IC₅₀: 1.14 μM	COX-2, IC₅₀: 0.18 μM
COX-1/2-IN-8		COX-1, IC₅₀: 2.14 ± 0.0 μM	COX-2, IC₅₀: 0.58 ± 0.0 μM
Meloxicam sodium		COX-1, IC₅₀: 36.6 μM	COX-2, IC₅₀: 0.49 μM
Balanophonin			COX-2
COX-2-IN-23		COX-1, IC₅₀: 20.14 μM	COX-2, IC₅₀: 0.28 μM
WYZ90		COX-1, IC₅₀: 5734 nM	COX-2, IC₅₀: 75 nM
COX-2-IN-43		COX-1, IC₅₀: 0.983 μM	COX-2, IC₅₀: 0.247 μM
Floctafenine		COX-1	COX-2
Pifoxime		COX-1	COX-2
Longiferone B			COX-2
COX-2/sEH-IN-1		COX-1, IC₅₀: 8.72 μM	COX-2, IC₅₀: 1.24 μM
COX-2-IN-14			COX-2
COX-2-IN-24			COX-2, IC₅₀: 0.17 μM
Tolmetin sodium		Human COX-1, IC₅₀: 0.35 μM	Human COX-2, IC₅₀: 0.82 μM
COX-2-IN-49			COX-2, IC₅₀: 2.671 μM
COX-2-IN-22			COX-2, IC₅₀: 8.6 μM
Indazole-Cl			COX-2		98.72%
(S)-(+)-Ibuprofen-d₃		COX-1, IC₅₀: 2.1 μM	COX-2, IC₅₀: 1.6 μM		98.87%
COX-2-IN-47			COX-2, IC₅₀: 0.03 μM
COX-2/NLRP3-IN-1			COX-2, IC₅₀: 1.53 μM
COX-1/2-IN-2		COX-1, IC₅₀: 9.7±0.09 μM	COX-2, IC₅₀: 4.6±1.45 μM
COX-2-IN-34			COX-2, IC₅₀: 0.42 μM
Anti-inflammatory agent 56			COX-2
Taraxerol acetate		COX-1, IC₅₀: 116.3 μM	COX-2, IC₅₀: 94.7 μM
Jaceosidin (Standard)			COX-2
COX-2/PI3K-IN-2			COX-2, Ki: 3.02 nM
COX-2-IN-32			COX-2
COX-2-IN-16			COX-2, IC₅₀: 102 μM
ARN14494			COX-2
COX-2-IN-42			COX-2
COX-2-IN-20		COX-1, IC₅₀: 19.3 μM	COX-2, IC₅₀: 17.9 nM
COX-2-IN-48			Human COX-2, IC₅₀: 51.7 nM
COX-2/PI3K-IN-1			COX-2, Ki: 3.24 nM
COX-2-IN-40			COX-2, IC₅₀: 14.86 μM
Akt/NF-κB/JNK-IN-1			COX-2
COX-2-IN-35			COX-2, IC₅₀: 4.37 nM
COX-2-IN-31		COX-1, IC₅₀: 12.5 μM	COX-2, IC₅₀: 60 nM
Clematomandshurica saponin B			COX-2
COX-2-IN-10			COX-2
Ginsenoside Rb3 (Standard)			COX-2
Daturaolone		COX-1
Kadsulignan N			COX-2
Flunixin		COX-1, IC₅₀: 0.55 μM	COX-2, IC₅₀: 3.24 μM
COX-2-IN-5			COX-2, IC₅₀: 0.65 μM
Anti-inflammatory agent 78		COX-1	COX-2
Shizukaol B			COX-2
Lucidone			COX-2
Topo I/COX-2-IN-2			COX-2, IC₅₀: 2.31 μM
COX-1/2-IN-1		COX-1, IC₅₀: 9.7±0.09 μM	COX-2, IC₅₀: 4.6±1.45 μM
Nimesulide-d₅			COX-2, IC₅₀: 0.07-70 μM
COX-2/LOX-IN-1			COX-2, IC₅₀: 0.55 μM
Bromfenac		Human COX-1, IC₅₀: 5.56 nM	Human COX-2, IC₅₀: 7.45 nM
COX-2-IN-46			COX-2, IC₅₀: 87.74 nM
TX-1123		COX-1, IC₅₀: 15.7 μM	COX-2, IC₅₀: 1.16 nM
Axinelline A		COX-1, IC₅₀: 8.89 μM	COX-2, IC₅₀: 2.22 μM
4,4'-Dihydroxy-2,6-dimethoxydihydrochalcone		COX-1	COX-2		99.64%
Salicylic acid (Standard)			COX-2
COX-2-IN-28		COX-1, IC₅₀: 13.21 μM	COX-2, IC₅₀: 0.054 μM
Desmethyl Celecoxib			COX-2, IC₅₀: 32 nM		99.42%
COX-2-IN-29		COX-1, IC₅₀: > 10 μM	COX-2, IC₅₀: 0.005 μM
Loxoprofen sodium (dihydrate)		COX-1, IC₅₀: 6.5 μM (in human whole blood)	COX-2, IC₅₀: 13.5 μM (in human whole blood)
COX-2/15-LOX-IN-1		COX-1, IC₅₀: 10.65 μM	COX-2, IC₅₀: 0.075 μM
COX-1-IN-1		COX-1, IC₅₀: 0.23 μM	COX-2, IC₅₀: 50 μM
Ermanin			COX-2
Catechin hydrate		COX-1, IC₅₀: 1.4 μM
Fenoprofen Calcium	COX
ZLJ-6		COX-1, IC₅₀: 0.73 μM	COX-2, IC₅₀: 0.31 μM
BF389		COX-1, IC₅₀: 4 μg/mL	COX-2, IC₅₀: 8 μg/mL
Tenidap sodium		COX-1	COX-2
NCX 466		COX-1	COX-2
LY 178002	Cyclooxygenase
Flosulide			COX-2
Thioflosulide			COX-2, IC₅₀: 2.3 nM
S-2474		COX-1, IC₅₀: 27 μM	COX-2, IC₅₀: 11 nM
LFS-1107			COX-2
COX-1/2-IN-9		COX-1, IC₅₀: 0.031 μM	COX-2, IC₅₀: 0.010 μM
COX-2-IN-1			COX-2, IC₅₀: 3.9 μM
Timegadine	COX, IC₅₀: 5 nM (in rabbit platelets) COX, IC₅₀: 20 μM (in rat brain)
Tilmacoxib			Human COX-2, IC₅₀: 85 nM		≥99.0%
COX/5-LO-IN-1	COX
COX-2-IN-2			COX-2, IC₅₀: 240 nM		99.53%

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4